《大行報告》大摩料華潤置地(01109.HK)未來60日股價將跑贏行業
摩根士丹利發表報告表示,預料華潤置地(01109.HK)將強化市場領導地位和實現正面的盈利增長,未來60日股價將跑贏行業,發生機率80%以上。予其目標價35.4元,及「增持」評級。
報告指,潤地近期股價調整後,短期估值更有吸引力。該行指,公司推出了豐富的項目,令合同銷售增長較同行優勝;積極的土地購買和高質量的土地儲備,提高了市場整合的能見度;受惠於較低的土地成本,毛利率前景穩定;以及今年租金收入強勁,預計明年和後年亦將有強勁反彈。該行認為,自10月中旬以來,同行的第三季度業績疲軟,對盈利擔憂已基本被消化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.